Life science companies need to harness the predictive value of data to drive deeper process understanding. Here’s how.

As the biopharmaceutical industry begins to embrace advanced data collection and analysis tools, it finds itself facing a challenging question: How can drug manufacturers best harness all that data to improve capacity, reduce bottlenecks and cut costs?